Menu

A screenshot of the manufacturer notices on the Health Resources and Services Administration’s Office of Pharmacy Affairs website.

UCB, Johnson & Johnson and Baxter notified covered entities of refunds, while Baxter and Amgen announced new National Drug Codes for certain products.

Three Drugmakers To Refund 340B Covered Entities for Overcharges, Two Announce NDC Changes

January 27, 2026 340B Report Staff 340B Report Views

Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2008 and 2023, while two unveiled [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

340B Report Staff

Expert Tip from SpendMend

State 340B Contract Pharmacy Access Bills Move in Washington, Iowa